177 related articles for article (PubMed ID: 35268038)
1. Association between Physical Activity and Non-Alcoholic Fatty Liver Disease in Adults with Metabolic Syndrome: The FLIPAN Study.
Mascaró CM; Bouzas C; Montemayor S; Casares M; Gómez C; Ugarriza L; Borràs PA; Martínez JA; Tur JA
Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268038
[TBL] [Abstract][Full Text] [Related]
2. Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
Montemayor S; Bouzas C; Mascaró CM; Casares M; Llompart I; Abete I; Angullo-Martinez E; Zulet MÁ; Martínez JA; Tur JA
Nutrients; 2022 May; 14(11):. PubMed ID: 35684022
[TBL] [Abstract][Full Text] [Related]
3. Impact of Physical Activity Differences Due to COVID-19 Pandemic Lockdown on Non-Alcoholic Fatty Liver Parameters in Adults with Metabolic Syndrome.
Mascaró CM; Bouzas C; Montemayor S; García S; Mateos D; Casares M; Gómez C; Ugarriza L; Borràs PA; Martínez JA; Tur JA
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745100
[TBL] [Abstract][Full Text] [Related]
4. Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
Montemayor S; Mascaró CM; Ugarriza L; Casares M; Llompart I; Abete I; Zulet MÁ; Martínez JA; Tur JA; Bouzas C
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956364
[TBL] [Abstract][Full Text] [Related]
5. Association between Stages of Hepatic Steatosis and Physical Activity Performance in Adults with Metabolic Syndrome: A Cross-Sectional Analysis in FLIPAN Study.
Mascaró CM; Bouzas C; Montemayor S; Casares M; Gómez C; Ugarriza L; Borràs PA; Martínez JA; Tur JA
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565758
[TBL] [Abstract][Full Text] [Related]
6. Effect of a Six-Month Lifestyle Intervention on the Physical Activity and Fitness Status of Adults with NAFLD and Metabolic Syndrome.
Mascaró CM; Bouzas C; Montemayor S; Casares M; Llompart I; Ugarriza L; Borràs PA; Martínez JA; Tur JA
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565780
[TBL] [Abstract][Full Text] [Related]
7. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Metabolic Syndrome and Nonalcoholic Fatty Liver Disease among Premenopausal and Postmenopausal Women in Ho Municipality: A Cross-Sectional Study.
Setroame AM; Kormla Affrim P; Abaka-Yawson A; Kwadzokpui PK; Eyram Adrah F; Bless H; Mohammed L; Bawah AT; Alidu HW
Biomed Res Int; 2020; 2020():2168381. PubMed ID: 32420328
[TBL] [Abstract][Full Text] [Related]
9. Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features.
Bullón-Vela V; Abete I; Tur JA; Pintó X; Corbella E; Martínez-González MA; Toledo E; Corella D; Macías M; Tinahones F; Fitó M; Estruch R; Ros E; Salas-Salvadó J; Daimiel L; Zulet MA; Martínez JA;
Nutrition; 2020 Mar; 71():110620. PubMed ID: 31838461
[TBL] [Abstract][Full Text] [Related]
10. Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study.
Chen LW; Huang MS; Shyu YC; Chien RN
Kaohsiung J Med Sci; 2021 Sep; 37(9):819-827. PubMed ID: 34002481
[TBL] [Abstract][Full Text] [Related]
11. Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review.
Mascaró CM; Bouzas C; Tur JA
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010923
[TBL] [Abstract][Full Text] [Related]
12. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
13. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic Fat Content and COVID-19 Lockdown in Adults with NAFLD and Metabolic Syndrome.
Montemayor S; Mascaró CM; Ugarriza L; Casares M; Gómez C; Martínez JA; Tur JA; Bouzas C
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079720
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
Hou XH; Zhu YX; Lu HJ; Chen HF; Li Q; Jiang S; Xiang KS; Jia WP
J Gastroenterol Hepatol; 2011 Apr; 26(4):722-30. PubMed ID: 21418302
[TBL] [Abstract][Full Text] [Related]
16. Association between alanine aminotransferase as surrogate of fatty liver disease and physical activity and sedentary time in adolescents with obesity.
Julian V; Bergsten P; Ennequin G; Forslund A; Ahlstrom H; Ciba I; Dahlbom M; Furthner D; Gomahr J; Kullberg J; Maruszczak K; Morwald K; Olsson R; Pixner T; Schneider A; Pereira B; Ring-Dimitriou S; Thivel D; Weghuber D
Eur J Pediatr; 2022 Aug; 181(8):3119-3129. PubMed ID: 35771354
[TBL] [Abstract][Full Text] [Related]
17. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
Sogabe M; Okahisa T; Kurihara T; Takehara M; Kagemoto K; Okazaki J; Kida Y; Hirao A; Tanaka H; Tomonari T; Taniguchi T; Okamoto K; Nakasono M; Takayama T
PLoS One; 2020; 15(8):e0238388. PubMed ID: 32866186
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].
Yu TP; Zhao CC; Chen MY; Lu JX; Li LX; Jia WP
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2398-2402. PubMed ID: 30138983
[No Abstract] [Full Text] [Related]
19. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
[TBL] [Abstract][Full Text] [Related]
20. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
